Metraipolis › archive › dc_fe8ff1437005

Bridging the gap in OA therapeutics: Bioengineered strategies to target osteoclast-chondrocyte crosstalk — Europe PMC PMID:42272963

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42272963
DOI
10.1002/btm2.70107
License (as archived)
solo-consultazione
Archived
2026-11-06T22:06:28.074Z
SHA-256 of the archived text
041423c37d0fe2d5c5208a8809e75f3065359cb7fbae6d9b355f2067d932791f
Stable URL of this page
https://metraipolis.com/documento/dc_fe8ff1437005

How to cite

Bridging the gap in OA therapeutics: Bioengineered strategies to target osteoclast-chondrocyte crosstalk — Europe PMC PMID:42272963 — Europe PMC (en), https://europepmc.org/article/MED/42272963 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fe8ff1437005 (Metraipolis archive dc_fe8ff1437005, sha256 041423c37d0fe2d5c5208a8809e75f3065359cb7fbae6d9b355f2067d932791f)
BibTeX
@misc{dcfe8ff1437005,
  title = {Bridging the gap in OA therapeutics: Bioengineered strategies to target osteoclast-chondrocyte crosstalk — Europe PMC PMID:42272963},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42272963},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fe8ff1437005; sha256 041423c37d0fe2d5c5208a8809e75f3065359cb7fbae6d9b355f2067d932791f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42272963. Agents can read the archived copy with the MCP tool read_document.